CAS No. |
290304-24-4 |
中文名称 |
Daun02 |
英文名称 |
Daun02 |
别名 |
Daun02;(8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-[[[[4-(beta-D-galactopyranosyloxy)-3-nitrophenyl]methoxy]carbonyl]amino]-alpha-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione;DAUN 02; DAUN-02;5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-[[[[4-(β-D-galactopyranosyloxy)-3-nitrophenyl]methoxy]carbonyl]amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)- |
标准英文名 |
3-nitro-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)benzyl ((2S,3S,4S,6R)-6-(((1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)-3-hydroxy-2-methyltetrahydro-2H-pyran-4-yl)carbamate |
分子式 |
C41H44N2O20 |
分子量 |
884.80
|
精确分子量 |
884.25
|
SMILES |
O=C(OCC1=CC=C(O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)C([N+]([O-])=O)=C1)N[C@@H]3[C@H](O)[C@H](C)O[C@@H](O[C@H]4C[C@](O)(C(C)=O)CC5=C(O)C6=C(C(C7=C(OC)C=CC=C7C6=O)=O)C(O)=C45)C3 |
标准SMILES |
CC(=O)[C@]1(O)CC2C([C@H](C1)O[C@H]1C[C@H](NC(=O)OCC3C=C(C(=CC=3)O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[N+]([O-])=O)[C@H](O)[C@H](C)O1)=C(O)C1=C(C(=O)C3=CC=CC(OC)=C3C1=O)C=2O |
用途 |
Daun02 is a prodrug of the topoisomerase inhibitor daunorubicin, selectively activated by β-galactosidase to exert cytotoxic effects; it is used as a research tool to study β-galactosidase activity and targeted drug activation in cancer cells; it reduces calcium ion (Ca²⁺)-dependent action potentials in neuroblastoma cells; it demonstrates potent anti-proliferative activity against various cancer cell lines, including T47-D, Panc02, and MCF-7, with EC50 values of 0.5 μM, 1.5 μM, and 3.5 μM, respectively. |
InChIKey |
BOIXMGNMIWJAEW-LCTCPDETSA-N |